B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 1.5642 NOK -5.02% Market Closed
Market Cap: 61.1m NOK

Intrinsic Value

BGBIO's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one BGBIO stock under the Base Case scenario is 0.2029 NOK. Compared to the current market price of 1.5642 NOK, Bergenbio ASA is Overvalued by 87%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BGBIO Intrinsic Value
0.2029 NOK
Overvaluation 87%
Intrinsic Value
Price
B
Base Case Scenario

Valuation History
Bergenbio ASA

BGBIO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BGBIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Bergenbio ASA
OSE:BGBIO
NO
Biotechnology
Market Cap
61.1m NOK
IPO
Apr 7, 2017
NO
Biotechnology
Market Cap
61.1m NOK
IPO
Apr 7, 2017
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BGBIO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bergenbio ASA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bergenbio ASA

Current Assets 154.5m
Cash & Short-Term Investments 140.2m
Receivables 8.9m
Other Current Assets 5.5m
Non-Current Assets 1.3m
PP&E 1.3m
Other Non-Current Assets -1k
Efficiency

Free Cash Flow Analysis
Bergenbio ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bergenbio ASA

Revenue
848k NOK
Operating Expenses
-152.1m NOK
Operating Income
-151.2m NOK
Other Expenses
12m NOK
Net Income
-139.3m NOK
Fundamental Scores

BGBIO Profitability Score
Profitability Due Diligence

Bergenbio ASA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 1-Year Revenue Growth
Positive 3-Years Revenue Growth
Declining ROE
32/100
Profitability
Score

Bergenbio ASA's profitability score is 32/100. The higher the profitability score, the more profitable the company is.

BGBIO Solvency Score
Solvency Due Diligence

Bergenbio ASA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
78/100
Solvency
Score

Bergenbio ASA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BGBIO Price Targets Summary
Bergenbio ASA

Wall Street analysts forecast BGBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BGBIO is 5.1 NOK with a low forecast of 5.05 NOK and a high forecast of 5.25 NOK.

Lowest
Price Target
5.05 NOK
223% Upside
Average
Price Target
5.1 NOK
226% Upside
Highest
Price Target
5.25 NOK
236% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Bergenbio ASA
does not pay dividends
Shareholder Yield

Current shareholder yield for BGBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one BGBIO stock?

The intrinsic value of one BGBIO stock under the Base Case scenario is 0.2029 NOK.

Is BGBIO stock undervalued or overvalued?

Compared to the current market price of 1.5642 NOK, Bergenbio ASA is Overvalued by 87%.

Back to Top